Repotrectinib (TPX-0005) is a next-generation ROS1/TRK/ALK inhibitor that potently inhibits ROS1/TRK/ALK solvent- front mutations - Drilon, A; Ou, S I; Cho, B C (Cancer Discov, 2018)